• English
  • Sign In
  • Contact Us
×
Catalog Products » Recombinant Proteins » OX40/TNFRSF4, His, Human

OX40/TNFRSF4, His, Human

OX40/TNFRSF4, His, Human

Immobilized OX40 His, human at 2 μg/mL (100 μL/well) can bind Biotin-OX40L His, Human with a linear range of 1.22-19.53 ng/mL.

Species Human
Protein Construction

OX40/TNFRSF4 (Leu29-Ala216)
Accession # P43489
Poly-His
N-term C-term
Purity > 95% as analyzed by SDS-PAGE
Endotoxin Level < 0.2 EU/μg of protein by gel clotting method
Biological Activity Immobilized OX40 His, human at 2.0 μg/ml (100 µl/well) can bind Biotin-OX40L His, Human when detected by Streptavidin-HRP.
Expression System HEK 293
Apparent Molecular Weight 40~45 kDa, on SDS-PAGE under reducing conditions.
Formulation Lyophilized from a 0.2 μm filtered solution in PBS, 5% trehalose and mannitol.
Reconstitution It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH₂O or PBS up to 100 μg/ml.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at lower than -70°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. For long term storage it is recommended that a carrier protein (example 0.1% BSA) be added. Avoid repeated freeze-thaw cycles.

  • OX40/TNFRSF4, His, Human
  • OX40/TNFRSF4, His, Human

    Immobilized OX40 His, human at 2 μg/mL (100 μL/well) can bind Biotin-OX40L His, Human with a linear range of 1.22-19.53 ng/mL.


Target Background OX40 is a T cell co-stimulatory molecule of the TNF receptor superfamily that coordinates with other co-stimulators (CD28, CD40, CD30, CD27 and 4-1BB) to manage the activation of the immune response. Tumor necrosis factor ligand superfamily member 4 (TNFSF4) is also known as glycoprotein Gp34, OX40 ligand (OX40L), TAX transcriptionally-activated glycoprotein 1 and CD252, which belongs to the tumor necrosis factor family. TNFSF4 is the ligand for CD134 and is expressed on cells such as DC2s (a subtype of dendritic cells) enabling amplification of Th2 cell differentiation. OX40 is constitutively expressed on Tregs and enhances the sensitivity of Tregs to IL-2, thus promoting Treg proliferation. OX40 has also shown to decrease the cells’ immunosuppressive activity on effector T cells. OX40-OX40 Ligand signaling is involved in allergic airway inflammation, graft-versus-host disease and autoimmune disease.
Synonyms ACT-135; ACT35 antigen; ACT35; CD134 antigen; CD134; Ly-70; OX40 cell surface antigen; OX40 homologue; OX40; OX40L receptor; OX40lymphoid activation antigene ACT35

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.




Notice there is no results found, you can visit "Citations Database" for other results.





For more documents, please visit "Technical Support".

Cat. No. Z03438
Size Price
100 μg $250.00
1 mg $1200.00